PPI-1025

N/A

Report date: 2023/02/09 15:59:44
NME

Base Information

Drug NamePPI-1025
Drug Alias NamePPI-1025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasmalogen replacements
TargetsNot applicable
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaval University / Université Laval
China Registration ClassN/A

Develop Information

Active CompaniesMed-Life Discoveries Lp
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A